Skip to main content
Contact Us
Subscribe
E-Edition
50°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LILLY DRN
Recent news which mentions LILLY DRN
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
Tags
Weight management
LILLY DRN
Health care policy
From
CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
December 20, 2024
Tags
Science
LILLY DRN
Health & Science
From
CNBC.com News
5 things to know before the stock market opens Friday
December 20, 2024
Tags
Business News
Technology
5 Things to Know
From
CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
December 19, 2024
Tags
Health care industry
Business News
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
December 11, 2024
Tags
Biotech and Pharmaceuticals
Roche Holding AG
Novo Nordisk A/S
From
CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
December 11, 2024
Tags
Business
US: News
Biotechnology
From
CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
December 08, 2024
Tags
Pharmaceuticals
Meta Platforms Inc
Hims & Hers Health Inc
From
CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
December 05, 2024
Tags
Bristol/Myers Squibb Co
Healthy Returns
AstraZeneca PLC
From
CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
December 05, 2024
Tags
LILLY DRN
Companies
Health & Science
From
CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
December 04, 2024
Tags
Novo Nordisk A/S
Business
US: News
From
CNBC.com News
5 things to know before the stock market opens Tuesday
November 26, 2024
Tags
Politics
Earnings
Macy's Inc
From
CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
November 26, 2024
Tags
Pharmaceuticals
Breaking news
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
November 19, 2024
Tags
Health care industry
Biotech and Pharmaceuticals
Amgen Inc
From
CNBC.com News
Cramer's Lightning Round: Eli Lilly is a buy
November 18, 2024
Tags
stocks
Mad Money
Apple Inc
From
CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
November 15, 2024
Tags
Bristol/Myers Squibb Co
Stock markets
Markets
From
CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
November 12, 2024
Tags
Biotechnology
Business
US: News
From
CNBC.com News
‘Two-stocks’ are better than one? Repacking ‘pair trades'
November 09, 2024
Tags
U/S/ Markets
Media
Technology
From
CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
Tags
Healthy Returns
AstraZeneca PLC
Social issues
From
CNBC.com News
Jim Cramer says CEOs must properly explain the bad news in every quarter
October 30, 2024
Tags
Business
Investing
Investment strategy
From
CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024
Tags
Novo Nordisk A/S
Biotechnology
Business
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
October 30, 2024
Tags
Health care industry
US: News
Business
From
CNBC.com News
Jim Cramer's top 10 things to watch in the stock market Wednesday
October 30, 2024
Tags
Reddit Inc
GE HealthCare Technologies Inc
Alphabet Inc
From
CNBC.com News
Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance
October 30, 2024
Tags
Breaking News: Business
LILLY DRN
Breaking News: Earnings
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
Tesla Inc
New York Times Co
Amgen Inc
From
CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
October 25, 2024
Tags
Reddit Inc
Alphabet Inc
Microsoft Corp
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
Tags
Biotechnology
US: News
Business
From
CNBC.com News
Cramer's Lightning Round: 'Wait for a pullback' with Eli Lilly
October 23, 2024
Tags
stocks
Mad Money
Investment Strategy
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
October 23, 2024
Tags
Healthy Returns
Social issues
Health & Science
From
CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
October 23, 2024
Tags
Health & Science
Companies
LILLY DRN
From
CNBC.com News
KKM Financial's Essential 40 stock fund is now an ETF
October 21, 2024
Tags
Investment strategy
Markets
Wall Street
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.